Modern biotechnology-based therapeutic approaches against HIV infection.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Biomedical Reports

• Publication date

  2017-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/br.2017.1006PMID 29250325PMCID PMC5727756
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An analysis of possible off target effects following CAS9/CRISPR targeted deletions of neuropeptide gene enhancers from the mouse genome

  2017cited by this paper
• Pakistan needs to speed up its human immunodeficiency virus control strategy to achieve targets in fast-track acquired immune deficiency syndrome response

  2017cited by this paper
• Re-engineered RNA-Guided FokI-Nucleases for Improved Genome Editing in Human Cells.

  2017cited by this paper
• Development of Lentiviral Vectors Simultaneously Expressing Multiple siRNAs Against CCR5, vif and tat/rev Genes for an HIV-1 Gene Therapy Approach

  2016cited by this paper
• HIV‐1 and hijacking of the host immune system: the current scenario

  2016cited by this paper
• HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities

  2016cited by this paper
• Origins of Programmable Nucleases for Genome Engineering.

  2016cited by this paper
• Recombinant Adeno-Associated Virus Vector Genomes Take the Form of Long-Lived, Transcriptionally Competent Episomes in Human Muscle

  2016cited by this paper
• Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodies

  2016cited by this paper
• Trends in AIDS Deaths, New Infections and ART Coverage in the Top 30 Countries with the Highest AIDS Mortality Burden; 1990–2013

  2015cited by this paper
• CCR5 Gene Disruption via Lentiviral Vectors Expressing Cas9 and Single Guided RNA Renders Cells Resistant to HIV-1 Infection

  2014cited by this paper
• Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.

  2014cited by this paper
• Rapamycin Ameliorates Inflammation and Fibrosis in the Early Phase of Cirrhotic Portal Hypertension in Rats through Inhibition of mTORC1 but Not mTORC2

  2014cited by this paper
• CRISPR-Cas systems for editing, regulating and targeting genomes

  2014cited by this paper
• Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.

  2013cited by this paper
• HIV transmission.

  2012cited by this paper
• HIV: cell binding and entry.

  2012cited by this paper
• RNA-based Gene Therapy for the Treatment and Prevention of HIV: From Bench to Bedside

  2011cited by this paper
• Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation.

  2011cited by this paper
• Emerging nanotechnology approaches for HIV/AIDS treatment and prevention.

  2010cited by this paper
• Macrophage Delivery of Nanoformulated Antiretroviral Drug to the Brain in a Murine Model of NeuroAIDS1

  2009cited by this paper
• Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation.

  2009cited by this paper
• X-ray structures of the hexameric building block of the HIV capsid.

  2009cited by this paper
• Nanoparticles in Medicine: Therapeutic Applications and Developments

  2008cited by this paper
• Nanoparticle therapeutics: an emerging treatment modality for cancer

  2008cited by this paper
• The structural biology of HIV assembly.

  2008cited by this paper
• Radiolabeling, pharmacoscintigraphic evaluation and antiretroviral efficacy of stavudine loaded 99mTc labeled galactosylated liposomes.

  2008cited by this paper
• Nanotechnology for drug delivery: the perfect partnership

  2008cited by this paper
• Not just sheer luck! Immune correlates of protection against HIV-1 infection.

  2008cited by this paper
• Design of extended short hairpin RNAs for HIV-1 inhibition

  2007cited by this paper
• Nanotechnology applications in cancer.

  2007cited by this paper
• Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates

  2007cited by this paper
• Chlorofullerene C60Cl6: a precursor for straightforward preparation of highly water-soluble polycarboxylic fullerene derivatives active against HIV.

  2007cited by this paper
• Influence of Generation 2–5 of PAMAM Dendrimer on the Inhibition of Tat Peptide/ TAR RNA Binding in HIV‐1 Transcription

  2006cited by this paper
• HIV-1 coreceptors and their inhibitors.

  2006cited by this paper
• Elite control of HIV infection: implications for vaccines

  2006cited by this paper
• Cancer nanotechnology: opportunities and challenges

  2005cited by this paper
• Anti-HIV properties of cationic fullerene derivatives.

  2005cited by this paper
• Lentiviral delivery of short hairpin RNAs protects CD4 T cells from multiple clades and primary isolates of HIV.

  2005cited by this paper
• Intrabodies as drug discovery tools and therapeutics.

  2005cited by this paper
• Genetic Fate of Recombinant Adeno-Associated Virus Vector Genomes in Muscle

  2003cited by this paper
• siRNA-directed inhibition of HIV-1 infection

  2002cited by this paper
• Modulation of HIV-1 replication by RNA interference

  2002cited by this paper
• Redox State of Single Chain Fv Fragments Targeted to the Endoplasmic Reticulum, Cytosol and Mitochondria

  1995cited by this paper
• Ligand-induced redistribution of a human KDEL receptor from the Golgi complex to the endoplasmic reticulum.

  1992cited by this paper
• The accuracy of reverse transcriptase from HIV-1.

  1988cited by this paper
• Acquired immune deficiency syndrome: an overview of central nervous system complications and neuropsychological sequelae.

  1986cited by this paper

• A demographic study on causes of hepatitis transitions among theagricultural community

  2022cites this paper
• A Study On Causes And Community Response Regarding Diabatie As A Community Diseaes Of Southern Punjab Pakistan

  2022cites this paper
• In vitro anti-viral effects of small heat shock proteins 20 and 27: A novel therapeutic approach.

  2019cites this paper
• Introductory Chapter: Gene Editing Technologies and Applications

  2019cites this paper
• Anti-viral effects of superpositively charged mutant of green fluorescent protein.

  2019cites this paper
• Chloro-1,4-dimethyl-9H-carbazole Derivatives Displaying Anti-HIV Activity

  2018cites this paper
• Current and Future Therapeutic Strategies for Lentiviral Eradication from Macrophage Reservoirs

  2018cites this paper
• Tackling HIV Persistence: Pharmacological versus CRISPR-Based Shock Strategies

  2018cites this paper